Moore K, Phillips S, Kromash R, Siebert S, Roberts W, Peltier M
Stigma Health. 2024; 9(2):224-235.
PMID: 39381322
PMC: 11456775.
DOI: 10.1037/sah0000483.
El-Sabawi T, Gillespie K
AMA J Ethics. 2024; 26(7):E520-526.
PMID: 38958420
PMC: 11293620.
DOI: 10.1001/amajethics.2024.520.
Arbaugh S, Chambers L, Gaither R, Hallowell B, Daly M, Marshall B
R I Med J (2013). 2024; 107(7):22-27.
PMID: 38917311
PMC: 11476007.
Eckhardt A, Waller D, Shull S, Lovejoy T, Morasco B, Gordon A
Subst Use Addctn J. 2024; 45(4):674-681.
PMID: 38767274
PMC: 11458360.
DOI: 10.1177/29767342241251761.
Dunham K, Rivas C, Medina Blanco P, Kolod B, Salvati C, Clark K
J Gen Intern Med. 2024; 39(9):1681-1689.
PMID: 38578536
PMC: 11255174.
DOI: 10.1007/s11606-024-08743-5.
Leveraging neuroscience education to address stigma related to opioid use disorder in the community: a pilot study.
Kyzar E, Arbuckle M, Abba-Aji A, Balachandra K, Cooper J, Dela Cruz A
Front Psychiatry. 2024; 15:1360356.
PMID: 38563031
PMC: 10982477.
DOI: 10.3389/fpsyt.2024.1360356.
First-hand accounts of structural stigma toward people who use opioids on Reddit.
Eschliman E, Choe K, DeLucia A, Addison E, Jackson V, Murray S
Soc Sci Med. 2024; 347:116772.
PMID: 38502980
PMC: 11031276.
DOI: 10.1016/j.socscimed.2024.116772.
Psychological Distress Mediates the Relationship Between HIV-Related Stigma and Prescription Opioid Misuse Among Chinese People Living with HIV.
Tam C, Harrison S, Benotsch E, Litwin A, Zhou Y, Shen Z
AIDS Behav. 2024; 28(5):1673-1683.
PMID: 38334862
DOI: 10.1007/s10461-024-04288-0.
Insufficient Impact: Limited Implementation of Federal Regulatory Changes to Methadone and Buprenorphine Access in Arizona During COVID-19.
Meyerson B, Bentele K, Brady B, Stavros N, Russell D, Mahoney A
AJPM Focus. 2024; 3(2):100177.
PMID: 38312524
PMC: 10835120.
DOI: 10.1016/j.focus.2023.100177.
Addressing the Spectrum of Opioid Misuse Prevention, Treatment, and Recovery in Rural Washington State Communities: Provider Identified Barriers and Needs.
Kriegel L, Hampilos K, Weybright E, Weeks D, Jett J, Hill L
Community Ment Health J. 2024; 60(3):600-607.
PMID: 38200378
PMC: 11257748.
DOI: 10.1007/s10597-023-01215-w.
Mobile treatment for opioid use disorder: Implementation of community-based, same-day medication access interventions.
Chatterjee A, Baker T, Rudorf M, Walt G, Stotz C, Martin A
J Subst Use Addict Treat. 2023; 159:209272.
PMID: 38128649
PMC: 10947870.
DOI: 10.1016/j.josat.2023.209272.
Toward a Psychological Model of Chemical Coping with Opioids in Cancer Care.
Yusufov M, Pirl W, Braun I, Sannes T, McHugh R
Harv Rev Psychiatry. 2023; 31(6):259-266.
PMID: 37948154
PMC: 11060627.
DOI: 10.1097/HRP.0000000000000384.
Latent class analysis of perceived stigma among older adults receiving medications for opioid use disorder.
Mitchell M, Angelo S, Akinwolere O, Perkins M, Bender A
J Subst Use Addict Treat. 2023; 156:209187.
PMID: 37858796
PMC: 10843650.
DOI: 10.1016/j.josat.2023.209187.
A conceptual framework for how structural changes in emerging acute substance use service models can reduce stigma of medications for opioid use disorder.
Becker T, Eschliman E, Thakrar A, Yang L
Front Psychiatry. 2023; 14:1184951.
PMID: 37829763
PMC: 10565357.
DOI: 10.3389/fpsyt.2023.1184951.
The Incidence and Disparities in Use of Stigmatizing Language in Clinical Notes for Patients With Substance Use Disorder.
Weiner S, Lo Y, Carroll A, Zhou L, Ngo A, Hathaway D
J Addict Med. 2023; 17(4):424-430.
PMID: 37579100
PMC: 10387497.
DOI: 10.1097/ADM.0000000000001145.
"I don't want to die": a qualitative study of coping strategies to prevent fentanyl-related overdose deaths among people who inject drugs and its implications for harm reduction policies.
Abadie R
Harm Reduct J. 2023; 20(1):75.
PMID: 37316884
PMC: 10264884.
DOI: 10.1186/s12954-023-00805-x.
Use of nonstigmatizing language is associated with improved outcomes in hospitalized people who inject drugs.
Carpenter J, Catalanotti J, Notis M, Brokus C, Moran T, Akselrod H
J Hosp Med. 2023; 18(8):670-676.
PMID: 37286190
PMC: 10524912.
DOI: 10.1002/jhm.13146.
Adapting psychotherapy in collaborative care for treating opioid use disorder and co-occurring psychiatric conditions in primary care.
French R, Worley J, Lowenstein M, Bogner H, Calderbank T, DePhilippis D
Fam Syst Health. 2023; 41(3):377-388.
PMID: 37227828
PMC: 10517081.
DOI: 10.1037/fsh0000791.
Association Between Hospital Adoption of an Emergency Department Treatment Pathway for Opioid Use Disorder and Patient Initiation of Buprenorphine After Discharge.
Solomon K, OConnor J, Gibbons J, Kilaru A, Feder K, Xue L
JAMA Health Forum. 2023; 4(3):e230245.
PMID: 36961457
PMC: 10313142.
DOI: 10.1001/jamahealthforum.2023.0245.
Impact of Stigma on Clinician Training for Opioid Use Disorder Care: A Qualitative Study in a Primary Care Learning Collaborative.
Klusaritz H, Bilger A, Paterson E, Summers C, Barg F, Cronholm P
Ann Fam Med. 2023; 21(Suppl 2):S31-S38.
PMID: 36849482
PMC: 9970664.
DOI: 10.1370/afm.2920.
